Rabl, M., Zullo, L., Lewczuk, P., Kornhuber, J., Karikari, T. K., Blennow, K., . . . Popp, J. (2024). Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression. Alzheimer's Research & Therapy, 16(1), . https://doi.org/10.1186/s13195-024-01526-4
Chicago-referens (17:e uppl.)Rabl, Miriam, et al. "Plasma Neurofilament Light, Glial Fibrillary Acid Protein, and Phosphorylated Tau 181 as Biomarkers for Neuropsychiatric Symptoms and Related Clinical Disease Progression." Alzheimer's Research & Therapy 16, no. 1 (2024). https://doi.org/10.1186/s13195-024-01526-4.
MLA-referens (9:e uppl.)Rabl, Miriam, et al. "Plasma Neurofilament Light, Glial Fibrillary Acid Protein, and Phosphorylated Tau 181 as Biomarkers for Neuropsychiatric Symptoms and Related Clinical Disease Progression." Alzheimer's Research & Therapy, vol. 16, no. 1, 2024, https://doi.org/10.1186/s13195-024-01526-4.
